Fully independent validation and updating of a clinical pharmacy prioritizing risk score in an infectious disease hospital ward.

Autor: Dos Santos Barreto PG; Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundations, Rio de Janeiro, Brazil., Barbosa Rezende R; Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundations, Rio de Janeiro, Brazil., Dos Santos AL; Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundations, Rio de Janeiro, Brazil., de Oliveira Silva F; Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundations, Rio de Janeiro, Brazil., Rodrigues Bezerra Góis V; Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundations, Rio de Janeiro, Brazil., Corsino Freire E; Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundations, Rio de Janeiro, Brazil., Alvarenga Americano do Brasil PE; Evandro Chagas National Institute of Infectious Diseases - Oswaldo Cruz Foundations, Rio de Janeiro, Brazil.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Aug; Vol. 88 (8), pp. 3695-3708. Date of Electronic Publication: 2022 Mar 26.